Zimmer Biomet (ZBH) is an American healthcare company, manufacturing products and solutions to treat arthritis and traumatic injuries, and restore mobility. Established in 1927 and headquartered in Warsaw, Indiana, USA, the company maintains world-class scientific facilities in more than 24 countries and markets its products in more than 100 countries worldwide. Zimmer’s global team includes approximately 8,500 employees. Zimmer Biomet is listed on the New York Stock Exchange (NYSE) and is a member of the S&P 500. Read more about the Zimmer Biomet share price at Capital.com.